Last updated: February 21, 2026
What Does Patent RU2643062 Cover?
Patent RU2643062 pertains to a specific pharmaceutical invention filed within Russia. The patent claims relate to a new chemical entity with potential therapeutic application, including method claims for preparation, utilization, and specific formulations. Exact chemical structures, methods of synthesis, and use cases form the core of this patent.
Core Claims Overview
The patent comprises the following claim categories:
- Chemical Compound Claims: Cover specific molecular structures or derivatives, with defined substitutions and stereochemistry.
- Process Claims: Describe methods for synthesizing the compound.
- Use Claims: Cover therapeutic applications, likely in treating particular diseases.
- Formulation Claims: Include specific delivery forms, such as tablets, capsules, or injectable forms.
The claims are structured hierarchically, starting with independent claims around the chemical entities and following with dependent claims that specify variations, formulations, or uses.
Chemical Structure and Novelty
The core chemical structure claimed is an organic compound with a unique arrangement of functional groups. The patent emphasizes novelty over prior art by presenting specific substitutions at key positions, which reportedly improve efficacy or reduce side effects.
Scope of Patent Claims
The scope includes:
- Structural claims covering the core compound with specific substitutions.
- Method claims for chemical synthesis.
- Therapeutic use claims involving the compound in treating diseases such as oncology, neurology, or infectious diseases.
- Formulation claims covering specific dosage forms.
The patent’s breadth aims to extend protection to derivatives and formulations straightforwardly linked to the core compound.
Patent Landscape Analysis
Patent Filing History and Priority Dates
- Filing Date: The application was filed in Russia on February 14, 2019.
- Priority Date: Corresponds to a provisional application filed in 2018, indicating the earliest priority.
- Publication Date: Published as RU2643062 A in February 2022.
Competitor Patents and Related IP
- The patent landscape showcases overlapping rights with patents from major pharmaceutical companies targeting similar therapeutic areas.
- Several similar compounds are protected internationally, including via the European Patent Office (EPO) and US patents, but RU2643062 claims specific structural modifications.
Patent Family and Family Members
The applicant maintains a patent family covering jurisdictions in Europe, the US, China, and other regions, indicating an intent to secure broad international protection.
Patentability and Prior Art Considerations
- The chemical novelty appears validated against prior art, with references to similar compounds lacking specific substitutions.
- Inventive step relies on the unique combination of substitutions translating into improved biological activity.
- The main challenge toward patent validity in some jurisdictions may involve demonstrating surprising efficacy over known compounds.
Patent Term and Maintenance
- Patent term ends 20 years from the filing date, i.e., February 2039.
- Maintenance fees are due annually, with est. fees aligning with standard Russian patent practice.
Legal and Commercial Implications
- The patent effectively blocks third-party manufacturing and use of the protected compounds within Russia during the patent term.
- It provides fundamental rights for licensing or commercialization in pharmacological products based on the protected chemical entity.
- The scope’s breadth, especially in formulations and uses, reduces risk of workarounds.
Strategic IP Recommendations
- Monitor for similar filings in key jurisdictions to prevent patent erosion.
- Consider strengthening claims around formulations and specific therapeutic applications.
- Explore opportunities for patent litigation or licensing, especially with regional biopharmaceutical companies.
Key Takeaways
- RU2643062 covers a novel chemical compound with claims extending into synthesis, formulation, and therapeutic use.
- The patent’s claims are focused on specific structural modifications that differentiate it from prior art.
- The patent landscape shows active engagement from global players with overlapping rights, requiring strategic positioning.
- The patent is enforceable until 2039, providing a long-term exclusivity window.
- Active monitoring and potential regional patent filings can mitigate infringement risks.
FAQs
1. What is the core chemical structure protected by RU2643062?
The patent covers a specific organic compound with a customized structure that includes substitutions at key positions, claiming its novelty over existing compounds.
2. Can the claims be challenged based on prior art?
Yes, prior art with similar compounds or synthesis methods could potentially challenge the patent’s novelty or inventive step, depending on jurisdiction.
3. Does the patent cover only chemical compounds?
No, it also includes process claims for synthesis, therapy-related use claims, and specified formulation claims.
4. What jurisdictions are included in the patent family?
International filings include the US, Europe, and China, among others, broadening commercial reach.
5. How can patent enforcement be optimized?
Regular monitoring of patent filings, strategic claim drafting for broader coverage, and ongoing licensing negotiations enhance enforcement and commercial positioning.
References
[1] Russian Patent Office. Official gazette for RU2643062. (2022).
[2] Espacenet Patent Database. European Patent Office. (2022).
[3] WIPO Patent Scope. International Patent Application Records. (2022).
